Skip to main content
Clinical Trials/IRCT20210518051335N1
IRCT20210518051335N1
Not yet recruiting
Phase 2

Evaluation and comparison of the efficacy of triple therapies regimens containing bismuth with high dose and different doses of amoxicillin for eradicating Helicobacter pylori infection

Mazandaran University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mazandaran University of Medical Sciences
Enrollment
200
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients have H. pylori eradication indication based on endoscopic evidence
  • Patients with positive Rapid urease test
  • Patients with positive histology of H. pylori infection

Exclusion Criteria

  • Age under 18 years
  • Reluctance to participate in the study
  • Pregnancy and lactation
  • Patients taking concomitant anticoagulants, corticosteroids or ketoconazole.
  • Patients with a history of gastric surgery
  • Patients with a history of heart failure, lung disease, chronic kidney failure, liver disease (cirrhosis or chronic hepatitis for any reason), or a history of cancer
  • Consumption of alcohol in any amount
  • The presence of any type of malignancy
  • History of drug allergy to the drugs in this study
  • History of H. pylori eradication regimens at any time before this study

Outcomes

Primary Outcomes

Not specified

Similar Trials